1) residual leukemic cells
残留白血病细胞
1.
Objective To explore the impact of the percentage of bone marrow residual leukemic cells at theend of induction chemotherapy(T1:day 5-7of induction therapy) or during aplasia(T2:7-10 daysafter the end of induction therapy) on the prognosis of patients with de novo acute myeloidleukemia(AML).
目的 探讨原发初治急性髓系白血病(AML)诱导缓解治疗末(T1：化疗第5-7天)及骨髓抑制期(T2：化疗结束后7-10天)两时点残留白血病细胞比例的预后价值。
2) Minimal residual leukemia cells (MRLC)
微量残留白血病细胞
4) residual leukocyte
残留白细胞
5) minimal residual disease
微小残留白血病
1.
Although some patients with leukemia have achieved complete remission according to the clinical and morphological criteria,there are still very low numbers of malignant cells that can not be discriminated by morphology and remained in bone marrow,which is called minimal residual disease(MRD)and is the main reason leading to relapse.
微小残留白血病(MRD)是指白血病经化疗缓解后在骨髓中仍存在形态上不能检测到的白血病细胞,是白血病复发的主要原因。
2.
To explore a simple and easy method to detect the minimal residual disease (MRD) in children with acute lymphoblastic leukemia (ALL), DNA was extracted from stored bone marrow smears with chelex 100 at different periods in 41 children with ALL.
为探讨一种简便易行检测儿童急性淋巴细胞性白血病 (AL L)微小残留白血病 (MRD)的方法 ,应用 Chelex10 0为介质抽提 4 1例 AL L 患儿不同病期未染色骨髓涂片 DNA,以 TCR Vδ2 Dδ3基因重排为标志 ,采用极限稀释定量PCR法扩增 ,动态监测 MRD的消长与临床病情变化的关系。
6) minimal residual leukemia
微小残留白血病
1.
Quantitative detection of minimal residual leukemia cells in peripheral blood and clinical application;
外周血微小残留白血病细胞的定量检测及临床应用
2.
Effect of Yiqi Yangyin method on the multiple resistance factors of minimal residual leukemia
益气养阴法对微小残留白血病多药耐药相关因子的影响
3.
This study aimed to investigate the pathophysiology and therapy of multi-drug resistant model of minimal residual leukemia in mice.
为了方便研究多药耐药微小残留白血病的病理生理和治疗,采用携带绿荧光蛋白(EGFP)基因标记的小鼠多药耐药白血病细胞系P388/VCRG和DBA小鼠建立一个检测多药耐药微小残留白血病的动物模型。
补充资料：白细胞不增多性白血病
白细胞不增多性白血病
病的一种临床类型。此种病人周围血中白细胞不增多，甚至低于正常，血液中较难发现异常幼稚细胞，故又有人称之为"非白血性白血病"。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条